T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
$2.5B |
| 2 |
Kenvue
KVUE
|
$1.3B |
| 3 |
Halliburton
HAL
|
$1.16B |
| 4 |
Charles Schwab
SCHW
|
$836M |
| 5 |
Boeing
BA
|
$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.52B |
| 2 |
Apple
AAPL
|
$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
$1.47B |
| 5 |
Intuit
INTU
|
$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
XP
XP
$9.96B
| $107M | 0.02% |
4,636,717
-44,863
| -1% | -$1.03M |
|
502
BioMarin Pharmaceuticals
BMRN
$11.1B
| $107M | 0.02% |
1,204,831
-86,847
| -7% | -$7.68M |
|
503
Peloton Interactive
PTON
$3.27B
| $106M | 0.02% |
21,078,484
+167,646
| +0.8% | +$847K |
|
|
MRTX
504
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $106M | 0.02% |
2,433,029
+655,450
| +37% | +$28.6M |
|
505
Emerson Electric
EMR
$74.6B
| $105M | 0.02% |
1,091,144
-5,838
| -0.5% | -$564K |
|
506
Lantheus
LNTH
$3.72B
| $105M | 0.02% |
1,507,231
-19,555
| -1% | -$1.36M |
|
507
Gartner
IT
$18.6B
| $104M | 0.02% |
301,905
+825
| +0.3% | +$283K |
|
508
Capital One
COF
$142B
| $103M | 0.02% |
1,062,556
-147,851
| -12% | -$14.3M |
|
509
Duke Energy
DUK
$93.8B
| $103M | 0.02% |
1,163,968
+44,598
| +4% | +$3.94M |
|
510
Quanta Services
PWR
$55.5B
| $102M | 0.01% |
545,177
-84,503
| -13% | -$15.8M |
|
511
Blackstone
BX
$133B
| $102M | 0.01% |
947,974
+509,670
| +116% | +$54.6M |
|
512
Ivanhoe Electric
IE
$1.18B
| $101M | 0.01% |
8,461,786
+5,459,496
| +182% | +$65M |
|
513
Replimune Group
REPL
$494M
| $99.1M | 0.01% |
5,793,199
+60,187
| +1% | +$1.03M |
|
514
International Flavors & Fragrances
IFF
$16.9B
| $99.1M | 0.01% |
1,453,333
-421,571
| -22% | -$28.7M |
|
515
Exelixis
EXEL
$10.2B
| $97.7M | 0.01% |
4,472,824
-475,990
| -10% | -$10.4M |
|
516
Gaming and Leisure Properties
GLPI
$13.7B
| $97.3M | 0.01% |
2,136,096
+624,162
| +41% | +$28.4M |
|
517
Emcor
EME
$28B
| $96.7M | 0.01% |
459,743
-17,050
| -4% | -$3.59M |
|
518
CBRE Group
CBRE
$48.9B
| $96M | 0.01% |
1,299,820
+888,697
| +216% | +$65.6M |
|
519
Sarepta Therapeutics
SRPT
$1.96B
| $95.5M | 0.01% |
787,956
+7,035
| +0.9% | +$853K |
|
520
PTC
PTC
$25.6B
| $94.3M | 0.01% |
665,228
+39,595
| +6% | +$5.61M |
|
521
Mine Safety
MSA
$6.67B
| $92.3M | 0.01% |
585,276
+332,135
| +131% | +$52.4M |
|
522
VeriSign
VRSN
$26.2B
| $92.2M | 0.01% |
455,296
-326,282
| -42% | -$66.1M |
|
523
Wynn Resorts
WYNN
$12.6B
| $91.8M | 0.01% |
993,264
+1,435
| +0.1% | +$133K |
|
524
Fabrinet
FN
$13.2B
| $91.6M | 0.01% |
549,631
+2,224
| +0.4% | +$371K |
|
525
Zoom
ZM
$25B
| $91.4M | 0.01% |
1,306,848
-32,060
| -2% | -$2.24M |
|